IgE Depletion With Ligelizumab Does Not Significantly Improve Clinical Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis.
The Journal of investigative dermatology
View this publicationThe Journal of investigative dermatology
View this publicationCell host & microbe
View this publicationInternational journal of molecular sciences
View this publicationBMC pharmacology & toxicology
View this publicationExperimental dermatology
View this publicationSkinmed
View this publicationThe Journal of experimental medicine
View this publicationEndocrine connections
View this publicationmBio
View this publicationVASA. Zeitschrift fur Gefasskrankheiten
View this publication